When p53 expression in tumor cells was enhanced by SGT-53, we observed a significant decrease of Gal-1 at both the mRNA and protein levels while a control transfection with scL-vec nanocomplex did not change Gal-1 levels (Figure 6B,C). Here, LGALS1 is linked to neoplasm.